Nebulized fluticasone propionate, a viable alternative to systemic route in the management of childhood moderate asthma attack: A double-blind, double-dummy study

ÖZEN, AHMET; ÖZEN, AHMET; KIYKIM, AYÇA; ÖZEN, AHMET; ÖZEN, AHMET; ÖZEN, AHMET; Ozen, Ahmet; ÖZEN, AHMET; BARIŞ, SAFA; ÖZEN, AHMET

doi:10.1016/j.rmed.2015.07.007

Nebulized fluticasone propionate, a viable alternative to systemic route in the management of childhood moderate asthma attack: A double-blind, double-dummy study

ÖZEN A. O., ÖZEN A. O., KIYKIM A., ÖZEN A. O., ÖZEN A. O., ÖZEN A. O., ...Daha Fazla

RESPIRATORY MEDICINE, cilt.109, sa.9, ss.1120-1125, 2015 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 109 Sayı: 9
Basım Tarihi: 2015
Doi Numarası: 10.1016/j.rmed.2015.07.007
Dergi Adı: RESPIRATORY MEDICINE
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1120-1125
Anahtar Kelimeler: Nebulizer corticosteroid, Acute asthma attack, Children, REGULATORY T-CELLS, INHALED CORTICOSTEROIDS, ORAL PREDNISOLONE, CHILDREN, BUDESONIDE, EXPRESSION, CYTOKINE, EXACERBATION, THERAPY, ADJUNCT
İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet

Özet

Background: In this study, we compared the clinical and immunological efficacy of nebulized corticosteroid (CS) to systemic route during treatment of moderate asthma attack in children.